Shares of Recursion Pharmaceuticals ( RXRX -1.48%) fell this week. The stock lost 24% as of market close on Friday. The move ...

The cuts to three advanced drug programs were “inevitable” given the company’s “unsustainable cash burn,” one analyst wrote ...

Shares of Recursion Pharmaceuticals ( RXRX -11.15%) are tumbling on Tuesday. The stock lost 10.3% as of 2:50 p.m. ET and was ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it ...

We talk about news in cancer, updates on COVID's origin, and business news in biotech in this episode of Touching Base.

AI business Recursion Pharmaceuticals has narrowed its drug development pipeline, ending or pausing five programmes as it ...

Each function in this library is tested thoroughly and is not deoptimized by v8 (except some logging and comparison functions that can't be implemented without deoptimizations). This library ...